I try to present a reasoned argument why I believe Sarepta would be willing to pay for a solution to a significant problem it faces if it wants to either keep or receive any further marketing approvals for its PMO pipeline– and you respond dismissively by referring to rainbows and peachy posts and stating the bleeding obvious that a deal is needed….
- Forums
- ASX - By Stock
- PYC
- Ann: Successful Competitive Drug Evaluation in Animals
PYC
pyc therapeutics limited
Add to My Watchlist
3.63%
!
$1.29

Ann: Successful Competitive Drug Evaluation in Animals, page-14
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.29 |
Change
0.045(3.63%) |
Mkt cap ! $749.4M |
Open | High | Low | Value | Volume |
$1.25 | $1.29 | $1.25 | $337.0K | 265.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 300 | $1.23 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.29 | 58344 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 300 | 1.230 |
1 | 20000 | 1.220 |
1 | 1500 | 1.200 |
1 | 8000 | 1.135 |
1 | 2000 | 1.120 |
Price($) | Vol. | No. |
---|---|---|
1.285 | 58344 | 1 |
1.290 | 24500 | 1 |
1.300 | 8000 | 1 |
1.325 | 9001 | 1 |
1.330 | 10756 | 2 |
Last trade - 16.10pm 25/06/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |